Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
SRS Pharmaceuticals/SRS Life Sciences offers a diverse commercial portfolio targeting infectious disease and chronic conditions in emerging markets. Their products include antifungals ("anidulafungin", "caspofungin", "voriconazole"), antivirals ("favipiravir"), antibiotics/probiotics in novel forms (“Chewbiotics”), oncology drugs (“cladribine”, “idarubicin”, “trastuzumab”), cardiovascular agents (“adenosine”, “ticagrelor”), as well as innovative drug delivery systems like InStrip™ and BITs™. No clinical trial data found—company appears focused on commercialization rather than new molecular entity development.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on SRS Pharmaceuticals.